Collegium Pharmaceutical Inc is a pharmaceutical company that operates nationwide. Its core mission is to design and develop a diverse range of pain management therapies that incorporate its proprietary DETERx technology.
Operating as an independent entity in the pharmaceuticals industry, Collegium Pharmaceutical Inc produces innovative and novel products that focus on improving the patient experience. The company works on medications that make a difference for people with serious medical conditions. Its main medications are Oxycodone, Buprenorphine buccal film, tapentadol and naldemedine tablets.
Monitor the COLL share price by adding it to your eToro watchlist.